Has Paige Walton received payments from drug or device companies?

Yes. Drug and device makers reported $3,326 in general payments to Paige Walton across 117 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Paige Walton did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Paige Walton come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Paige Walton

Psychiatry · Charleston, SCNPI 1992290878

Payments from drug & device makers

$3,326in general payments, 2019–2025

Across 117 payments — averaging $28.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Axsome Therapeutics, Inc.$544
Johnson & Johnson$349
AbbVie$284
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$275
Neurocrine Biosciences, Inc.$187
Teva Pharmaceuticals USA, Inc.$171
plus $2K from 20 others

What the payments were for

Food & beverage$3,326100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Axsome Therapeutics, Inc.	21	$544
Johnson & Johnson	8	$349
AbbVie	15	$284
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	14	$275
Neurocrine Biosciences, Inc.	3	$187
Teva Pharmaceuticals USA, Inc.	3	$171
Corium, LLC	3	$149
Takeda Pharmaceuticals U.S.A., Inc.	5	$134
Neos Therapeutics, LP	2	$123
Sunovion Pharmaceuticals Inc.	1	$120
Acadia Pharmaceuticals Inc	2	$115
Noven Therapeutics, LLC	5	$100
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$97
Otsuka America Pharmaceutical, Inc.	4	$84
Idorsia Pharmaceuticals US Inc	5	$84
Tris Pharma Inc	4	$83
Bausch Health US, LLC	4	$77
Vanda Pharmaceuticals Inc.	3	$77
Collegium Pharmaceutical, Inc.	3	$56
Almatica Pharma LLC	3	$44
Livanova USA, Inc.	2	$44
E.r. Squibb & Sons, L.L.C.	2	$42
Janssen Scientific Affairs, LLC	1	$31
Lundbeck LLC	1	$22
Supernus Pharmaceuticals, Inc.	1	$18
Ironshore Pharmaceuticals Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,326 in reported general payments places this provider in the 80th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina →

Other psychiatry in Charleston

Jacobo MintzerCharleston$4.9M
Eduardo CifuentesCharleston$675K
Mark GeorgeCharleston$332K
Ricardo FermoCharleston$262K
Thomas UhdeCharleston$205K
Olga Brawman-MintzerCharleston$160K
Jessica BroadwayCharleston$146K
Floyd SalleeCharleston$121K
Kathleen BradyCharleston$110K
Constance GuilleCharleston$110K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →